RMC-6236-401 Daraxonrasib EAP

Study Details

Full Title

Expanded Access Program to Treat Patients with Previously Treated Metastatic Pancreatic Adenocarcinoma with Daraxonrasib

Principal Investigator

Niharika
Mettu

Protocol Number

PRO00120510

NCT ID

NA

Phase

N/A

Enrollment Status

Open to Enrollment